Comparison of Traditional Chinese Medicine with Western Medicine Cancer Therapy

被引:1
作者
Linlin Gao Xiongzhi Wu Chengdou University of Traditional Chinese MedicineChengdu Sichuan ProvinceChina Center of Integrative OncologyTianjin Medical University Cancer InstituteHospitalTianjin China [1 ,2 ,1 ,610075 ,2 ,300060 ]
机构
关键词
Chinese medicinal formula; chemotherapy; cancer;
D O I
暂无
中图分类号
R730.5 [肿瘤治疗学];
学科分类号
100214 ;
摘要
The interactions among drugs,tumor and host are critical for a response to therapy and for outcome.Anticancer herbs used in Chinese medicine are classified into 4 groups based on their target (tumor,patient and drug) as follows:eliminating pathogenic factors,strengthening the body resistance,enhancing effects of chemotherapy and detoxication of chemotherapy. Correspondingly,anticancer drugs used in Western medicine can be classified into 4 groups as follows:cytotoxic drugs,biological response modifiers,chemosensitizers and chemoprotectants. Based on the theory of Chinese medicinal formulas,prescriptions are composed of four constituents,namely,primary constituent (main component of the formula prescription),minister constituent (second component of formula prescription),adjuvant constituent (adjuvant component of the formula prescription) and messenger constituent (component making the formula prescription targeting pathological tissues).To control the interaction among drugs and to modulate the interaction among the tumor,patient and drugs,we suggest that combined therapy for Western medicine might include 4 constituents,i.e.,primary,cooperative,adjuvant and modulatory constituent. Cytotoxic drugs frequently are used as primary and cooperative constituents,whereas biological response modifiers and biochemical modulators are usually regarded respectively as adjuvant drugs and modulatory constituents. We believe these new concepts may be helpful for the aim of appropriately designing,evaluating or providing combination therapy.
引用
收藏
页码:231 / 234
页数:4
相关论文
共 50 条
[22]   TOXICITY OF A TRADITIONAL CHINESE MEDICINE, GANODERMA LUCIDUM, IN CHILDREN WITH CANCER [J].
Gill, Simerpal K. ;
Rieder, Michael J. .
JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2008, 15 (02) :E275-E285
[23]   Traditional Chinese medicine as dual guardians against hypertension and cancer? [J].
Tou, Weng Ieong ;
Chen, Calvin Yu-Chian .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2012, 30 (03) :299-317
[24]   How cancer patients build trust in traditional Chinese medicine [J].
Liu, Chun-Hao ;
Tang, Woung-Ru ;
Wang, Hung-Ming ;
Lee, Ko-Chen .
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2013, 5 (06) :495-500
[25]   Ferroptosis: a new mechanism of traditional Chinese medicine for cancer treatment [J].
Zhu, Jiahao ;
Shen, Peipei ;
Xu, Yu ;
Zhang, Xiaojun ;
Chen, Qingqing ;
Gu, Ke ;
Ji, Shengjun ;
Yang, Bo ;
Zhao, Yutian .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[26]   Traditional Chinese medicine and cancer: History, present situation, and development [J].
Liu, Jie ;
Wang, Shuo ;
Zhang, Ying ;
Fan, Hui-ting ;
Lin, Hong-sheng .
THORACIC CANCER, 2015, 6 (05) :561-569
[27]   Role of Traditional Chinese Medicine in Lung Cancer Management: A Review [J].
Rao, Zhijing ;
Wang, Zhongqi ;
Deng, Haibin ;
Su, Wan ;
Huang, Xiaowei ;
Xu, Zhenye .
AMERICAN JOURNAL OF CHINESE MEDICINE, 2025, 53 (01) :97-117
[28]   Current development in integrative therapy of traditional Chinese medicine for cancer treatment: A mini-review [J].
Su, Po-Hsuan ;
Tai, Chen-Jei .
JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE, 2020, 10 (05) :429-433
[29]   Behaviors of Providers of Traditional Korean Medicine Therapy and Complementary and Alternative Medicine Therapy for the Treatment of Cancer Patients [J].
Yu, Jun-Sang ;
Kim, Chun-Bae ;
Kim, Ki-Kyong ;
Lee, Ji-Eun ;
Kim, Min-Young .
JOURNAL OF PHARMACOPUNCTURE, 2015, 18 (01) :27-35
[30]   The Holistic Philosophy of Traditional Chinese Medicine and Conflicts With Modern Medicine [J].
Chien, Tsai-Ju .
HOLISTIC NURSING PRACTICE, 2023, 37 (03) :153-160